article thumbnail

Genomics England will move HQ to Canary Wharf’s new biocluster

pharmaphorum

Canary Wharf’s bid to become a new hub for the life sciences sector in the UK has been given a boost following the decision by Genomics England to relocate to the development. Genomics England will move into space at the iconic One Canada Square skyscraper (pictured) that was the EMA’s home before the move to the Netherlands.

Genome 111
article thumbnail

IBM sells off large parts of Watson Health business

pharmaphorum

Francisco Partners is picking up a range of databases and analytics tools – including Health Insights, MarketScan, Clinical Development, Social Programme Management, Micromedex and other imaging and radiology tools – for an undisclosed sum estimated to be in the region of $1 billion.

Radiology 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Advanced Diagnostics are Shaping the Future of Precision Medicine and Gene Therapy

Cloudbyz

Role of AI and ML in Diagnostics: Enhanced Data Analysis: AI and ML algorithms can process complex datasets from genomics, proteomics, and imaging studies more efficiently than human analysts. This enhances the identification of biomarkers and the understanding of disease mechanisms, accelerating the development of targeted therapies.

article thumbnail

Sophia Genetics launches AI tool to find COVID-19 ‘unknowns’

pharmaphorum

The data mining tool will be used to try to unearth some of the many unknowns with the virus, using next-generation sequencing (NGS) to see how the genome of SARS-CoV-2 changes over time, along with patient genetic information, results of lung and CT scans, and other clinical data.

Genetics 136
article thumbnail

The Utility of Liquid Biopsy in Oncology Clinical Trials

XTalks

These tumor-derived entities are used to derive genomic and proteomic data. Detection of Genomic Alterations from cfDNA: Targeted, Non-Personalized Approaches. Detection of Genomic Alterations from cfDNA: Personalized, Targeted Assays. Non-personalized approaches can be both in-house or through a service provider.

article thumbnail

The rise of real-world evidence: unlocking the potential in EHRs

pharmaphorum

“We’ve seen AI being used in a number of ways during the pandemic – from tracking genome mutations of COVID-19, to drug re-purposing and predictive models using machine learning for ICU and mortality rates. We’ve also seen some diagnostic AI tools for radiology distinguishing between pneumonia and COVID,” says Medrano.

Doctors 116